talazoparib,olaparib
pfizer,astrazeneca,merck
['sclc', 'lcsm,(-blcsm)', 'talazoparib', 'olaparib']
2 posters on temozomide &amp; parpi (olaparib or talazoparib) in relapsed es-sclc. remarkably similar rr ~40% similar mpfs 4-5 months mos 9-11 months cns activity (olaparib) myelosupression, manageable with dose or d1-7 q21d dosing #lcsm #asco22 
Thoracic medical oncologist | Consultant @ChelwestFT | Vice Chair @BTOGorg | Skier, when snow permits.